Next, the unbound fraction of semaglutide was measured in the presence of varying concentrations of immobilised HSA (from 1.9 to 26.7 M) either without icodec or with a ten-fold molar excess of icodec relative to semaglutide (i.e
In TNBC xenograft models and basal-like breast cancer, CB-839, either alone or in combination with paclitaxel, exhibits a potent antitumor effect (Gross et al., 2014)
Healthcare professionals should be aware that: Patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should be carefully evaluated before prescribing Routine calcitonin measurement is not recommended for patients without risk factors, as per UK guidance [23] [24] Patients should be counselled about symptoms of thyroid tumours, including a neck mass, dysphagia, dyspnoea, or persistent hoarseness The theoretical risk must be balanced against the proven cardiovascular and metabolic benefits of these medicines in appropriate patient populations
In February 2026, less than a year after its own drug was dropped, Pfizer announced that the long-acting GLP-1 drug it is now working on was progressing as hoped
